About Columbia Heart Clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Columbia Heart Clinic
During the past decade, Columbia Heart Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
2003-05-01
Completed
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
2004-08-18
Completed
144
Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery
2000-02-23
2013-01-31
Completed
815
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Columbia Heart Clinic" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Bristol-Myers Squibb" with 2 trials
sponsored, "Amgen" with 1 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored and "Sanofi"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia Heart Clinic"
#1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Columbia Heart Clinic
According to Clinical.Site data, the most researched conditions in "Columbia Heart Clinic" are
"Heart Failure" (2 trials), "ASCVD" (1 trials), "Acute Coronary Syndromes" (1 trials), "Angioplasty, Transluminal, Percutaneous Coronary" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Columbia Heart Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Columbia Heart Clinic
Most popular intervention types in "Columbia Heart Clinic" are "Drug" (5 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials), "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Columbia Heart Clinic
The vast majority of trials in "Columbia Heart Clinic" are
7 trials for "All" genders.
Clinical Trials Status at Columbia Heart Clinic
Currently, there are NaN active trials in "Columbia Heart Clinic".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Columbia Heart Clinic,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Columbia Heart Clinic, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".